Memorial Sloan Kettering Cancer Center
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1884-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mskcc.org
Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin
- Conditions
- Malignant Pleural DiseaseLung CancerMetastasesMesotheliomaBreast Cancer
- Interventions
- First Posted Date
- 2015-04-10
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 113
- Registration Number
- NCT02414269
- Locations
- 🇺🇸
Memorial Sloan Kettering Basking Ridge (Consent and Follow-Up), Basking Ridge, New Jersey, United States
🇺🇸Memorial Sloan Kettering Monmouth (Consent and Follow-Up), Middletown, New Jersey, United States
🇺🇸Memorial Sloan Kettering Bergen (Consent and Follow-Up), Montvale, New Jersey, United States
89Zr-J591 Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody in Patients With Glioblastoma Multiforme
- Conditions
- Glioblastoma
- Interventions
- First Posted Date
- 2015-04-07
- Last Posted Date
- 2019-03-19
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 2
- Registration Number
- NCT02410577
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Use of Contrast Enhanced Spectral Mammography (CESM) for Women With Palpable Breast Abnormalities
- Conditions
- Breast Abnormalities
- Interventions
- Other: Contrast Enhanced Spectral Mammography (CESM)
- First Posted Date
- 2015-04-02
- Last Posted Date
- 2024-06-28
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 249
- Registration Number
- NCT02406274
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Determinants of Bladder Cancer Recurrence Study (The DETER Study)
- Conditions
- Bladder Cancer
- Interventions
- Behavioral: questionnairesOther: Saliva and/or urine sample
- First Posted Date
- 2015-03-27
- Last Posted Date
- 2025-04-02
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 600
- Registration Number
- NCT02400944
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸Memorial Sloan Kettering Commack, Commack, New York, United States
🇺🇸Memorial Sloan Kettering Westchester, Harrison, New York, United States
Health Related Quality of Life Following Hepatectomy for Colorectal Liver Metastasis: Global and Disease Specific Changes Over Time
- Conditions
- Colorectal Liver Metastasis
- Interventions
- Behavioral: HRQoL questionnaires.
- First Posted Date
- 2015-03-26
- Last Posted Date
- 2025-04-09
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 219
- Registration Number
- NCT02399995
- Locations
- 🇺🇸
Memorial Sloan Kettering Basking Ridge (Consent and Follow up), Basking Ridge, New Jersey, United States
🇺🇸Memorial Sloan Kettering Bergen (Consent and Follow up), Montvale, New Jersey, United States
🇺🇸Memorial Sloan Kettering Commack (Consent and Follow up), Commack, New York, United States
Interrogation of Exosome-mediated Intercellular Signaling in Patients With Pancreatic Cancer
- Conditions
- Pancreatic CancerBenign Pancreatic Disease
- First Posted Date
- 2015-03-19
- Last Posted Date
- 2025-02-10
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 181
- Registration Number
- NCT02393703
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
DRIIVE (Data and Research on Interventions to Improve the Vehicular Environment)
- Conditions
- Vehicular Environment
- Interventions
- Device: HEPA air purifierBehavioral: questionnairesOther: Log-bookOther: Urine sample
- First Posted Date
- 2015-03-06
- Last Posted Date
- 2021-10-05
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 39
- Registration Number
- NCT02381626
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Metastatic Spinal Bone Marrow Response to Radiation Therapy Using T1 Weighted Dynamic Contrast-Enhanced Perfusion
- Conditions
- Solid CancerMetastatic Spinal Lesions
- Interventions
- Procedure: Dynamic contrast enhancement MRI
- First Posted Date
- 2015-03-03
- Last Posted Date
- 2024-10-29
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 25
- Registration Number
- NCT02376127
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Coping With Glioblastoma: A Study of Communication Between Physicians, Patients, and Caregivers
- Conditions
- GlioblastomaBrain Cancer
- Interventions
- Behavioral: psychometric tests, questionnaires and neurocognitive assessments
- First Posted Date
- 2015-03-03
- Last Posted Date
- 2025-03-18
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 309
- Registration Number
- NCT02375841
- Locations
- 🇺🇸
Henry Ford Hospital, Detroit, Michigan, United States
🇺🇸Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
Testing a Personalize Medication Log for Patients With Lymphoma
- Conditions
- Lymphoma
- Interventions
- Other: personalized medication logOther: standard of careBehavioral: questionnairesBehavioral: Cognitive Interview
- First Posted Date
- 2015-02-25
- Last Posted Date
- 2017-01-11
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 5
- Registration Number
- NCT02370446
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States